Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas AnalgesiaDermatologyMedical DeviceNeuroscienceOncology & HematologyPediatricsRare DiseaseOtherCOVID-19Cell & Gene TherapyWomen's HealthDiagnosticsReal-World & Late Phase By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Target Product Profiles: Turning Discoveries into Companies By Premier Research July 12, 2017 Consulting Rushing Site Selection in Fibromyalgia Trials, Not a Great Idea By Scott Millard July 7, 2017 Clinical ResearchPhase 1 - Phase 4 8 Steps to Jump-Starting a CEC By Premier Research July 6, 2017 Clinical ResearchPhase 1 - Phase 4 The Top 5 Concerns for Pediatric Study Participants By Angi Robinson July 5, 2017 Clinical ResearchPhase 1 - Phase 4 5 Essential Factors for Navigating Early Stage Trials By Premier Research June 29, 2017 Consulting CECs: What Are They and Why Does Your Trial Need One? By Premier Research June 27, 2017 Previous 1 …32 33 34 35 36 … 46 Next × ALSO OF INTERESTGene Therapy 101: From the 1960s to TodayNostalgia or Shell Shock? Assessing PTSD Is a...Key Considerations When Designing a Phase 1...
